Apnimed (APMD) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 24 70 sessions, July 31, 2026 to November 6, 2026
- Largest daily move
- -14.3% close of October 6, 2026
- 1-month change
- -19% closing prices, October 6, 2026 to November 6, 2026
Company Description
Apnimed (NASDAQ: APMD) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $628.6M.
APMD has declined 19.0% over the past month. The last closing price was $15.10.
This page collects what Stock Titan holds for APMD, including price data, latest news, SEC filings, upcoming events, and short interest trends.
Stock Performance
Apnimed (APMD) closed at $15.10 on November 6, 2026. Over the past month, the price has lost 19.0%.
APMD Metrics & Rankings
Price returns through November 6, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Apnimed has 7 recent news articles, with the latest published 2 days ago. Of the recent coverage, 3 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings, IPO, offering. View all APMD news →
SEC Filings
Apnimed has filed 10 recent SEC filings, including 5 Form 4, 3 Form SCHEDULE 13G, 1 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all APMD SEC filings →
Financial Highlights
Upcoming Events
FDA decision date
Apnimed has 1 upcoming scheduled event. The next event, "FDA decision date", is scheduled for February 28, 2027 (in 113 days). Investors can track these dates to stay informed about potential catalysts that may affect the APMD stock price.
Short Interest History
Short interest in Apnimed (APMD) currently stands at 1.8 million shares, up 2.2% from the previous reporting period, representing 8.7% of the float. Since August 2026, short interest has increased by 342.6%.
Days to Cover History
Days to cover for Apnimed (APMD) currently stands at 3.9 days, up 85.2% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since August 2026, the figure has increased by 287%. Across the settlements charted above, it has ranged from 1.0 to 3.9 days.
APMD Company Profile & Sector Positioning
Apnimed (APMD) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing APMD often look at related companies in the same sector, including ArriVent BioPharma, Inc. (AVBP), 4D Molecular Therapeutics, Inc. (FDMT), Helus Pharma Inc. (HELP), Lexicon Pharmaceuticals, Inc. (LXRX), and Design Therapeutics, Inc. (DSGN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate APMD's relative position within its industry.